Literature DB >> 33282651

The Importance of Ultrasound in a Case of Stroke Caused by Left Atrial Myxoma.

Vincenzo Francesco Tripodi1, Carmelo Massimiliano Rao2, Angelo Covino1, Pasquale Fratto3, Frank Antonio Benedetto2.   

Abstract

Myxoma is one of the most common cardiac tumors. It is relatively straightforward to diagnose by echocardiography. Sometimes, It can causes cardiac syncope and thromboembolic events. A woman without comorbidities was admitted to our hospital with stroke symptoms: left-sided hemiplegia and dysarthria. After brain computed tomography (CT) and angio-CT value, she was initially treated with pharmacological thrombolysis. Due to persisting symptoms, cerebral angiography and thrombectomy were then performed. At the end of this procedure, the patient had a complete neurological recovery, but she developed new symptoms, such as dyspnea and orthopnea. Transthoracic echocardiogram and transesophageal echocardiogram showed an atrial mobile mass. Therefore, an urgent cardiac surgery was performed in order to remove the mass. Histological examination confirmed cardiac myxoma. Our experience could show the importance of echocardiography to early diagnosis. Copyright:
© 2020 Journal of Cardiovascular Echography.

Entities:  

Keywords:  Cardiac myxoma; echocardiography; stroke; thrombectomy; ultrasound

Year:  2020        PMID: 33282651      PMCID: PMC7706373          DOI: 10.4103/jcecho.jcecho_51_20

Source DB:  PubMed          Journal:  J Cardiovasc Echogr        ISSN: 2211-4122


INTRODUCTION

Myxoma is one of the most common cardiac tumors. Up to 90% of myxomas are located in the left atrium, with most of these tumors involving the atrial septum.[1] Cardiac myxomas are noncancerous primary tumors of the heart and constitute about 50% of all primary heart tumors. Myxomas occur most often in female patients aged 30–70 years.[2] In most cases, myxomas are solitary, but in their familial form, they can be multiple and recurrent. They may present with embolism, obstruction of intracardiac orifices, or systemic symptoms associated with cytokine release; sometimes, no symptoms occur at all.[1]

CASE REPORT

We present the case of a 66-year-old female who was admitted to the emergency room due to left-sided hemiplegia accompanied by dysarthria for a 3-h history of acute onset.[3] The patient had no other significant diseases and did not take any medications. At the neurological evaluation, the patient showed a deficit of left strength and difficulty in speaking with the National Institutes of Health Stroke Scale (NIHSS) <7.[45] Brain computed tomography (CT) and angio-CT showed the obstruction of the distal segment of the right middle cerebral artery. Alberta Stroke Program Early CT Score was 4. Intravenous pharmacological thrombolysis was performed with Recombinant tissue plasminogen activactor (rtPA) within 3 h of the onset of symptoms. No clinical improvement has occurred after the treatment, and NIHSS value was 11.[67] Brain angiography with thrombectomy and revascularization of the right middle cerebral artery was subsequently performed.[4] The patient had a complete neurological recovery but the onset of symptoms such as dyspnea and orthopnea. An atrial mobile mass, which was attached to the interatrial septum with partial prolapse into the left ventricle during systole, was detected by Transthoracic echocardiogram (TTE) [Figure 1].
Figure 1

Transthoracic echocardiogram (TTE) showing the mass during the cardiac cycle

Transthoracic echocardiogram (TTE) showing the mass during the cardiac cycle Transesophageal echocardiogram (TEE) confirmed the presence of an irregular pedunculated portion projecting and obstructing on the mitral valve and causing obstruction on the left ventricular outflow with significantly elevated pulmonary artery hypertension (45 mmHg) [Figure 2]. Mass measured was 4.5 cm × 2.2 cm. Left ventricular systolic function was mildly reduced.
Figure 2

Transesophageal echocardiogram (TEE) shows a large left atrial mass at the level of the mitral valve during systole and the prolapsing into the left ventricle during the diastolic cycle

Transesophageal echocardiogram (TEE) shows a large left atrial mass at the level of the mitral valve during systole and the prolapsing into the left ventricle during the diastolic cycle Anticoagulant and antithrombotic therapy was administered, urgent cardiac surgery was performed, and the mass was confirmed as a myxoma. Cardiopulmonary bypass was established with conventional mild hypothermia (32.0°C). During an anoxic arrest for 25 min with single aortic cross-clamping, the tumor of the interatrial septum was excised through an oblique and longitudinal atriotomy [Figure 3].
Figure 3

Postresection left atrial myxoma

Postresection left atrial myxoma Histological examination confirmed cardiac myxoma. She was extubated on the 1st day and then discharged on the 3rd day. She had an uncomplicated postoperative course.

DISCUSSION

Atrial myxoma is a rare cause of brain stroke requiring a thorough investigation to reach a diagnosis. Clinical manifestations of atrial myxoma are manifold and different. The patients usually present one of these diseases: arrhythmias, intracardiac flow obstruction, and embolic phenomena.[1] Myxoma could also cause acute paroxysmal dyspnea or syncope from “ball-valve blockade” of mitral orifice or mitral insufficiency from interfering with the mitral valve closure or damaging mitral leaflets.[2] Patients with left atrial myxoma usually present with signs and symptoms of thromboembolic events.[1] Certain conditions must be distinguished from myxoma such as thrombi, other primary cardiac tumors, metastases, and vegetations.[13] Transthoracic echocardiography, a noninvasive method, is considered the imaging modality of choice for the diagnosis of cardiac myxoma, but a transesophageal approach provides a better definition of the location and characteristics of the tumor with a sensitivity of almost 100%.[8] Two-dimensional echocardiography and color Doppler are the most common approaches used to diagnose myxoma and detect the hemodynamic changes.[9] Typically, a left atrial myxoma arises from the interatrial septum at the level of the fossa ovalis, whereas atrial thrombi classically reside in the atrial appendage and the atrial body.[10] In this clinical case, a pedicle attached to the left atrial lateral wall might have been the clue to the suspected diagnosis of myxoma. In atypical cases, cardiac CT or magnetic resonance imaging is recommended.[11]

CONCLUSIONS

Atrial myxoma is a rare cause of brain stroke. The gold standard for the diagnosis remains pathological evidence, but TTE and TEE are essential for proper diagnosis and treatment.[8] Surgical removal of cardiac mass remains the definitive treatment and is fundamental both to achieve the correct diagnosis and to avoid inferior vena cava occlusion or thromboembolic risks.[12] Ultrasound method increases their awareness of this disease and is able to the early diagnosis of such tumors. It is pertinent to have echocardiography done in patients who present with symptoms at hospital admission.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  12 in total

1.  Atrial Myxoma.

Authors:  M Usman Ali; Jonathan Finkel
Journal:  N Engl J Med       Date:  2018-10-18       Impact factor: 91.245

2.  A rare case of a cardiac calcified thrombus originating from right atrium and inferior vena cava.

Authors:  Stefano Cisico; Sara R Vacirca; Cristina Basso; Domenico Mangino
Journal:  J Card Surg       Date:  2020-02-04       Impact factor: 1.620

Review 3.  2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.

Authors:  William J Powers; Alejandro A Rabinstein; Teri Ackerson; Opeolu M Adeoye; Nicholas C Bambakidis; Kyra Becker; José Biller; Michael Brown; Bart M Demaerschalk; Brian Hoh; Edward C Jauch; Chelsea S Kidwell; Thabele M Leslie-Mazwi; Bruce Ovbiagele; Phillip A Scott; Kevin N Sheth; Andrew M Southerland; Deborah V Summers; David L Tirschwell
Journal:  Stroke       Date:  2018-01-24       Impact factor: 7.914

4.  Cardiac Myxoma and Ischemic Stroke.

Authors:  Lili Yuan; Liang Ge; Yujuan Zhu; Chu Chen; Zhiming Zhou; Qian Yang
Journal:  QJM       Date:  2020-03-06

5.  Thrombectomy or intravenous thrombolysis in patients with NIHSS of 5 or less?

Authors:  Valerio Da Ros; Jonathan Cortese; Olivier Chassin; Aymeric Rouchaud; Mariana Sarov; Jildaz Caroff; Cristian Mihalea; Silvia Minosse; Irina Taifas; Jacopo Scaggiante; Laura Greco; Leon Ikka; Nidhal Ben Achour; Francesca Di Giuliano; Augustin Ozanne; Nicolas Legris; Marina Diomedi; Fabrizio Sallustio; Roberto Floris; Christian Denier; Laurent Spelle
Journal:  J Neuroradiol       Date:  2019-01-16       Impact factor: 3.447

Review 6.  Cardiac Myxoma: A Rare Case Series of 3 Patients and a Literature Review.

Authors:  Haiyan Wang; Quan Li; Minghua Xue; Pengzhan Zhao; Jing Cui
Journal:  J Ultrasound Med       Date:  2017-05-27       Impact factor: 2.153

Review 7.  Left Atrial Myxoma Presenting as an Embolic Shower: A Case Report and Review of Literature.

Authors:  Julien Bernatchez; Valerie Gaudreault; Gabriel Vincent; Pascal Rheaume
Journal:  Ann Vasc Surg       Date:  2018-08-17       Impact factor: 1.466

8.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.

Authors:  William J Powers; Alejandro A Rabinstein; Teri Ackerson; Opeolu M Adeoye; Nicholas C Bambakidis; Kyra Becker; José Biller; Michael Brown; Bart M Demaerschalk; Brian Hoh; Edward C Jauch; Chelsea S Kidwell; Thabele M Leslie-Mazwi; Bruce Ovbiagele; Phillip A Scott; Kevin N Sheth; Andrew M Southerland; Deborah V Summers; David L Tirschwell
Journal:  Stroke       Date:  2019-10-30       Impact factor: 7.914

9.  Case report: left atrial Myxoma causing elevated C-reactive protein, fatigue and fever, with literature review.

Authors:  Jake Cho; Steven Quach; Justin Reed; Omeni Osian
Journal:  BMC Cardiovasc Disord       Date:  2020-03-05       Impact factor: 2.298

10.  Cardiac Myxoma and Cerebrovascular Events: A Retrospective Cohort Study.

Authors:  Maria-Ioanna Stefanou; Dominik Rath; Vera Stadler; Hardy Richter; Florian Hennersdorf; Henning F Lausberg; Mario Lescan; Simon Greulich; Sven Poli; Meinrad P Gawaz; Ulf Ziemann; Annerose M Mengel
Journal:  Front Neurol       Date:  2018-10-03       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.